Cargando…

Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration

Replacement of lost cranial bone (partly mesodermal and partly neural crest‐derived) is challenging and includes the use of nonviable allografts. To revitalize allografts, bone marrow‐derived mesenchymal stromal cells (mesoderm‐derived BM‐MSCs) have been used with limited success. We hypothesize tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaeser, Juliane D., Behrens, Phillip, Stefanovic, Tina, Salehi, Khosrowdad, Papalamprou, Angela, Tawackoli, Wafa, Metzger, Melodie F., Eberlein, Samuel, Nelson, Trevor, Arabi, Yasaman, Kim, Kevin, Baloh, Robert H., Ben‐David, Shiran, Cohn‐Schwartz, Doron, Ryu, Robert, Bae, Hyun W., Gazit, Zulma, Sheyn, Dmitriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046069/
https://www.ncbi.nlm.nih.gov/pubmed/33512772
http://dx.doi.org/10.1002/sctm.20-0364
_version_ 1783678777135464448
author Glaeser, Juliane D.
Behrens, Phillip
Stefanovic, Tina
Salehi, Khosrowdad
Papalamprou, Angela
Tawackoli, Wafa
Metzger, Melodie F.
Eberlein, Samuel
Nelson, Trevor
Arabi, Yasaman
Kim, Kevin
Baloh, Robert H.
Ben‐David, Shiran
Cohn‐Schwartz, Doron
Ryu, Robert
Bae, Hyun W.
Gazit, Zulma
Sheyn, Dmitriy
author_facet Glaeser, Juliane D.
Behrens, Phillip
Stefanovic, Tina
Salehi, Khosrowdad
Papalamprou, Angela
Tawackoli, Wafa
Metzger, Melodie F.
Eberlein, Samuel
Nelson, Trevor
Arabi, Yasaman
Kim, Kevin
Baloh, Robert H.
Ben‐David, Shiran
Cohn‐Schwartz, Doron
Ryu, Robert
Bae, Hyun W.
Gazit, Zulma
Sheyn, Dmitriy
author_sort Glaeser, Juliane D.
collection PubMed
description Replacement of lost cranial bone (partly mesodermal and partly neural crest‐derived) is challenging and includes the use of nonviable allografts. To revitalize allografts, bone marrow‐derived mesenchymal stromal cells (mesoderm‐derived BM‐MSCs) have been used with limited success. We hypothesize that coating of allografts with induced neural crest cell‐mesenchymal progenitor cells (iNCC‐MPCs) improves implant‐to‐bone integration in mouse cranial defects. Human induced pluripotent stem cells were reprogramed from dermal fibroblasts, differentiated to iNCCs and then to iNCC‐MPCs. BM‐MSCs were used as reference. Cells were labeled with luciferase (Luc2) and characterized for MSC consensus markers expression, differentiation, and risk of cellular transformation. A calvarial defect was created in non‐obese diabetic/severe combined immunodeficiency (NOD/SCID) mice and allografts were implanted, with or without cell coating. Bioluminescence imaging (BLI), microcomputed tomography (μCT), histology, immunofluorescence, and biomechanical tests were performed. Characterization of iNCC‐MPC‐Luc2 vs BM‐MSC‐Luc2 showed no difference in MSC markers expression and differentiation in vitro. In vivo, BLI indicated survival of both cell types for at least 8 weeks. At week 8, μCT analysis showed enhanced structural parameters in the iNCC‐MPC‐Luc2 group and increased bone volume in the BM‐MSC‐Luc2 group compared to controls. Histology demonstrated improved integration of iNCC‐MPC‐Luc2 allografts compared to BM‐MSC‐Luc2 group and controls. Human osteocalcin and collagen type 1 were detected at the allograft‐host interphase in cell‐seeded groups. The iNCC‐MPC‐Luc2 group also demonstrated improved biomechanical properties compared to BM‐MSC‐Luc2 implants and cell‐free controls. Our results show an improved integration of iNCC‐MPC‐Luc2‐coated allografts compared to BM‐MSC‐Luc2 and controls, suggesting the use of iNCC‐MPCs as potential cell source for cranial bone repair.
format Online
Article
Text
id pubmed-8046069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-80460692021-04-16 Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration Glaeser, Juliane D. Behrens, Phillip Stefanovic, Tina Salehi, Khosrowdad Papalamprou, Angela Tawackoli, Wafa Metzger, Melodie F. Eberlein, Samuel Nelson, Trevor Arabi, Yasaman Kim, Kevin Baloh, Robert H. Ben‐David, Shiran Cohn‐Schwartz, Doron Ryu, Robert Bae, Hyun W. Gazit, Zulma Sheyn, Dmitriy Stem Cells Transl Med Tissue‐specific Progenitor and Stem Cells Replacement of lost cranial bone (partly mesodermal and partly neural crest‐derived) is challenging and includes the use of nonviable allografts. To revitalize allografts, bone marrow‐derived mesenchymal stromal cells (mesoderm‐derived BM‐MSCs) have been used with limited success. We hypothesize that coating of allografts with induced neural crest cell‐mesenchymal progenitor cells (iNCC‐MPCs) improves implant‐to‐bone integration in mouse cranial defects. Human induced pluripotent stem cells were reprogramed from dermal fibroblasts, differentiated to iNCCs and then to iNCC‐MPCs. BM‐MSCs were used as reference. Cells were labeled with luciferase (Luc2) and characterized for MSC consensus markers expression, differentiation, and risk of cellular transformation. A calvarial defect was created in non‐obese diabetic/severe combined immunodeficiency (NOD/SCID) mice and allografts were implanted, with or without cell coating. Bioluminescence imaging (BLI), microcomputed tomography (μCT), histology, immunofluorescence, and biomechanical tests were performed. Characterization of iNCC‐MPC‐Luc2 vs BM‐MSC‐Luc2 showed no difference in MSC markers expression and differentiation in vitro. In vivo, BLI indicated survival of both cell types for at least 8 weeks. At week 8, μCT analysis showed enhanced structural parameters in the iNCC‐MPC‐Luc2 group and increased bone volume in the BM‐MSC‐Luc2 group compared to controls. Histology demonstrated improved integration of iNCC‐MPC‐Luc2 allografts compared to BM‐MSC‐Luc2 group and controls. Human osteocalcin and collagen type 1 were detected at the allograft‐host interphase in cell‐seeded groups. The iNCC‐MPC‐Luc2 group also demonstrated improved biomechanical properties compared to BM‐MSC‐Luc2 implants and cell‐free controls. Our results show an improved integration of iNCC‐MPC‐Luc2‐coated allografts compared to BM‐MSC‐Luc2 and controls, suggesting the use of iNCC‐MPCs as potential cell source for cranial bone repair. John Wiley & Sons, Inc. 2021-01-29 /pmc/articles/PMC8046069/ /pubmed/33512772 http://dx.doi.org/10.1002/sctm.20-0364 Text en © 2020 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Tissue‐specific Progenitor and Stem Cells
Glaeser, Juliane D.
Behrens, Phillip
Stefanovic, Tina
Salehi, Khosrowdad
Papalamprou, Angela
Tawackoli, Wafa
Metzger, Melodie F.
Eberlein, Samuel
Nelson, Trevor
Arabi, Yasaman
Kim, Kevin
Baloh, Robert H.
Ben‐David, Shiran
Cohn‐Schwartz, Doron
Ryu, Robert
Bae, Hyun W.
Gazit, Zulma
Sheyn, Dmitriy
Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title_full Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title_fullStr Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title_full_unstemmed Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title_short Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
title_sort neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
topic Tissue‐specific Progenitor and Stem Cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046069/
https://www.ncbi.nlm.nih.gov/pubmed/33512772
http://dx.doi.org/10.1002/sctm.20-0364
work_keys_str_mv AT glaeserjulianed neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT behrensphillip neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT stefanovictina neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT salehikhosrowdad neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT papalamprouangela neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT tawackoliwafa neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT metzgermelodief neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT eberleinsamuel neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT nelsontrevor neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT arabiyasaman neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT kimkevin neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT balohroberth neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT bendavidshiran neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT cohnschwartzdoron neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT ryurobert neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT baehyunw neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT gazitzulma neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration
AT sheyndmitriy neuralcrestderivedmesenchymalprogenitorcellsenhancecranialallograftintegration